AllPeptides.eu - Advanced Peptide Research
    Single Peptides
    Healing

    GHK-Cu (200mg)

    Subcutaneously or TopicallyOnce daily (5 days/week)200mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    Research-only — Cosmetic (topical) use unrestricted

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Research-only — no FDA/EMA approval
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Available sizes:
    200mg
    50mg
    100mg

    Research monograph

    See the full GHK-Cu encyclopedia page with mechanism, evidence tier, related variants and research context.

    Open monograph
    Free Access

    How It Works

    GHK-Cu increases the synthesis of collagen, elastin, and proteoglycans. It also regulates metalloproteinases (MMPs) and growth factors, promoting skin regeneration and wound healing.

    Quick Start

    • Reconstitution: Add 10.0 mL bacteriostatic water → 20 mg/mL concentration.
    • Literature-reported range: 1–2 mg subcutaneously, once daily, 5 days/week.
    • Easy measurement: At 20 mg/mL, 1 mg = 5 units (0.05 mL) on a U-100 syringe.
    • Storage: 2–8 °C after reconstitution.
    Detailed Protocol Data

    Typical Approach (10 mL = 20 mg/mL)

    Educational only
    Vial Size— affects syringe units
    BAC Water10 mL
    Concentration20.00 mg/mL

    Route: Subcutaneously or Topically | Frequency: Once daily (5 days/week)

    WeekDoseUnits (per injection)
    Weeks 1–4
    1.0 mg
    5 Units (0.05 mL)
    Weeks 5–8
    1.5 mg
    7.5 Units (0.07 mL)
    Weeks 9–12
    2.0 mg
    10 Units (0.10 mL)

    Literature reports subcutaneous administration once daily, 5 days/week, usually capped at 2 mg per day. Can also be used topically in creams.

    Related compounds

    Reconstitution Steps

    1. Draw 10.0 mL of bacteriostatic water.
    2. Inject slowly.
    3. Swirl gently (do not shake).
    4. Refrigerate at 2–8 °C.

    Protocol Overview

    • Goal: Skin anti-aging, healing, collagen synthesis.
    • Schedule: 1–2 mg daily, 5 days/week × 8–12 weeks.

    Dosing Protocol

    • Start: 1 mg 1×/day, 5 days/week.
    • Titration: 1.5 mg (Wks 5–8) → 2 mg (Wks 9–12).
    • Cycle: 8–12 weeks.
    • Break between cycles: A 4-week break after the cycle.

    Washout & Cycle Restart

    When can I restart?

    A 4-week break after the cycle.

    Minimum wait period: 4 weeks

    Storage Instructions

    • Powder: −20 °C.
    • Solution: 2–8 °C, use within 28 days.

    Important Notes

    • The high content is considered a laboratory reference format.
    • Can be used in combination with BPC-157.
    • Topical use: mix into a base cream.
    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Increased collagen synthesis.
    • Improved skin texture and elasticity.
    • Anti-inflammatory action.
    • High cost-effectiveness at 200 mg.

    Potential Side Effects:

    • Injection site reactions (redness, itching — transient).
    • Local erythema or skin dryness (topical use).
    • Rare allergic reaction to the copper complex.

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    🎗️ Cancer Markers
    🟡 Moderate / Theoretical

    Angiogenesis & tissue remodeling

    GHK-Cu promotes angiogenesis, tissue regeneration, and increases collagen/elastin. Theoretical concern for enhancing existing tumors, though no clinical signal exists.

    📄 Life Sci 2012

    References

    1. J Biol Chem — GHK-Cu and collagen synthesis
      View Source
    2. Oxidative Med Cell Longev — GHK multifunctionality and anti-aging
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Research-only
    FDA Status
    0
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    Research peptide — No regulatory approval from any agency

    Research-only — Cosmetic (topical) use unrestricted

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu